Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-030688

Director bought 44,648 shares at an average $55.35 ($2,471,251)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamond David Director 2020-05-15 Purchase +1,263 $46.30 $58,478 1,654,599 I
Lamond David Director 2020-05-15 Purchase +985 $48.37 $47,640 1,655,584 I
Lamond David Director 2020-05-15 Purchase +1,600 $48.96 $78,333 1,657,184 I
Lamond David Director 2020-05-15 Purchase +1,000 $50.71 $50,707 1,658,184 I
Lamond David Director 2020-05-15 Purchase +500 $52.20 $26,101 1,658,684 I
Lamond David Director 2020-05-15 Purchase +100 $53.10 $5,310 1,658,784 I
Lamond David Director 2020-05-19 Purchase +400 $54.09 $21,636 1,659,184 I
Lamond David Director 2020-05-19 Purchase +5,906 $55.42 $327,309 1,665,090 I
Lamond David Director 2020-05-19 Purchase +32,894 $56.42 $1,855,738 1,697,984 I
Open-market purchases · 44,648 sh · avg $55.35 · $2,471,251
Loading xslF345X03/doc4.xml…